Arizona State Retirement System Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$144.95 - $152.29 $23,916 - $25,127	165 Added 1.02%	16,410 $2.48 Million
Q2 2022 Jul 28, 2022	BUY	$83.14 - $145.99 $25,773 - $45,256	310 Added 1.95%	16,245 $2.37 Million
Q1 2022 May 04, 2022	BUY	$110.08 - $142.92 $10,237 - $13,291	93 Added 0.59%	15,935 $1.89 Million
Q4 2021 Feb 04, 2022	SELL	$99.73 - $148.48 $11,070 - $16,481	-111 Reduced 0.7%	15,842 $2.18 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $127,417 - $179,054	1,289 Added 8.79%	15,953 $2.22 Million
Q2 2021 Aug 02, 2021	SELL	$65.78 - $105.02 $10,985 - $17,538	-167 Reduced 1.13%	14,664 $1.42 Million
Q1 2021 May 06, 2021	BUY	$64.07 - $91.75 $7,560 - $10,826	118 Added 0.8%	14,831 $1.01 Million
Q4 2020 Jan 28, 2021	SELL	$65.07 - $98.24 $19,455 - $29,373	-299 Reduced 1.99%	14,713 $1.26 Million
Q3 2020 Nov 05, 2020	BUY	$59.04 - $77.95 $226,123 - $298,548	3,830 Added 34.25%	15,012 $976,000
Q2 2020 Aug 04, 2020	BUY	$29.01 - $74.23 $21,960 - $56,192	757 Added 7.26%	11,182 $818,000
Q1 2020 May 05, 2020	BUY	$27.51 - $57.29 $286,791 - $597,248	10,425 New	10,425 $355,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.